amiloride hydrochloride (Cadila Healthcare Limited)
Welcome to the PulseAid listing for the amiloride hydrochloride drug offered from Cadila Healthcare Limited. This Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Cadila Healthcare Limited |
NON-PROPRIETARY NAME: | amiloride hydrochloride |
SUBSTANCE NAME: | AMILORIDE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-09-14 |
END MARKETING DATE: | 0000-00-00 |
amiloride hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | amiloride hydrochloride from Cadila Healthcare Limited |
LABELER NAME: | Cadila Healthcare Limited |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/1) |
START MARKETING DATE: | 2015-09-14 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 65841-820_7f1c21a2-07d4-4638-bc5c-1772373ef388 |
PRODUCT NDC: | 65841-820 |
APPLICATION NUMBER: | ANDA204180 |
Other AMILORIDE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: